medigraphic.com
ISSN 1561-2937 (Print)

2021, Number 3

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (3)

Prognostic utility of the SYNTAX score in patients with multiarterial coronary artery disease. 4-year follow-up

Naranjo-Dominguez A, Aroche AR, Hernández NM, Aldama L, Valdés MA, Vitón CAA

Language: Spanish
References: 41
Page: 1-10
PDF size: 679.33 Kb.


ABSTRACT

Introduction: The SYNTAX study provided the cardiology community with two great tools: the SYNTAX score and the role of the “Heart team”.
Objective: To determine the prognostic usefulness of the SYNTAX score in patients with a diagnosis of triarterial coronary disease or left main coronary artery revascularization in the CIMEQ during 2016.
Method: A prospective analytical observational cohort study. The study population consisted of 41 patients with a novo diagnosis of multiarterial coronary disease during 2016 who underwent myocardial revascularization surgery or percutaneous coronary intervention, for whom the SYNTAX score was calculated after intervention. Major cardiovascular events were followed for 48 months. Clinical and angiographic variables were studied.
Results: The variables heart failure (p = 0.046), revascularization modalities (p = 0.000), the number of lesions (p = 0.042), the extent of coronary disease involving TCI plus three vessels (p = 0.040) , total occlusions (p = 0.010), lesions that involved bifurcations / trifurcations (p = 0.044), severe calcification (p = 0.014) and tortuosity (p = 0.001) showed statistical association with the tertiles of the SYNTAX score. The mean follow-up was 28.5 months. In the upper tertile, revascularization surgery showed 58.3% of the patients free of adverse events at the end of the follow-up. Coronary intervention presented 50.0% and 42.9% of event-free patients in the middle and low tertiles, respectively, and zero percent survival in the upper stratum.
Conclusions: The SYNTAX score was of predictive value for adverse events in percutaneous coronary intervention in moderate and high tertiles. The SYNTAX score is adequate for stratifying patients to percutaneous coronary intervention or bypass surgery.


REFERENCES

  1. Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine [Internet]. 5 de marzo de 2009 [citado 15 de abril de 2021];360(10):961-72. Disponible en: https://doi.org/10.1056/NEJMoa0804626

  2. Mohr FW, Morice M-C, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. The Lancet [Internet]. 23 de febrero de 2013 [citado 15 de abril de 2021];381(9867):629-38. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673613601415

  3. Mohr FW, Davierwala PM. ESC/EACTS guidelines on myocardial revascularization post-SYNTAX. European Journal of Cardio-Thoracic Surgery [Internet]. 1 de octubre de 2014 [citado 15 de abril de 2021];46(4):511-3. Disponible en: https://doi.org/10.1093/ejcts/ezu346

  4. Serruys PW, Onuma Y, Garg S, Sarno G, Brand M van den, Kappetein A, et al. Assessment of the SYNTAX score in the Syntax study [Internet]. EuroIntervention. 2009 [citado 15 de abril de 2021]. Disponible en: https://eurointervention.pcronline.com/article/assessment-of-the-syntax-score-in-the-syntax-study

  5. Bundhun PK, Bhurtu A, Huang F. Worse clinical outcomes following percutaneous coronary intervention with a high SYNTAX score. Medicine (Baltimore) [Internet]. 16 de junio de 2017 [citado 15 de abril de 2021];96(24). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478325

  6. Chen J, Tang B, Lin Y, Ru Y, Wu M, Wang X, et al. Validation of the Ability of SYNTAX and Clinical SYNTAX Scores to Predict Adverse Cardiovascular Events After Stent Implantation: A Systematic Review and Meta-Analysis. Angiology [Internet]. 1 de octubre de 2016 [citado 15 de abril de 2021];67(9):820-8. Disponible en: https://doi.org/10.1177/0003319715618803

  7. Chung W-J, Chen C-Y, Lee F-Y, Wu C-C, Hsueh S-K, Lin C-J, et al. Validation of Scoring Systems That Predict Outcomes in Patients With Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting Surgery. Medicine (Baltimore) [Internet]. 12 de junio de 2015 [citado 15 de abril de 2021];94(23). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616463/

  8. Kim Young-Hak, Park Duk-Woo, Kim Won-Jang, Lee Jong-Young, Yun Sung-Cheol, Kang Soo-Jin, et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes After Unprotected Left Main Coronary Revascularization. JACC: Cardiovascular Interventions [Internet]. 1 de junio de 2010 [citado 15 de abril de 2021];3(6):612-23. Disponible en: https://www.jacc.org/doi/full/10.1016/j.jcin.2010.04.004

  9. Kang J, Han J-K, Kang D-Y, Zheng C, Yang H-M, Park K-W, et al. SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era. Korean Circulation Journal [Internet]. enero de 2020 [citado 15 de abril de 2021];50(1):22-34. Disponible en: https://doi.org/10.4070/kcj.2019.0097

  10. Hernández A de A, Rosales ER, Molina MÁC, Pérez DV. Sobrevida, estado clínico y calidad de vida al año de la cirugía cardiovascular. CorSalud [Internet]. 10 de febrero de 2017 [citado 15 de abril de 2021];6(1):18-24. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/175

  11. Blanco SR, Gómez JA, Pérez JC. Pacientes diabéticos con enfermedad coronaria multivaso tratados mediante intervencionismo coronario percutáneo. CorSalud [Internet]. 4 de noviembre de 2019 [citado 15 de abril de 2021];5(4):346-52. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/472

  12. Quert AYL, Alcázar MAA, Recarey MAV, Gómez JA, Ortiz JLM, Tamayo JB, et al. Resultados al año del intervencionismo coronario percutáneo multiarterial. CorSalud [Internet]. 2014 [citado 15 de abril de 2021];6(3):211-6. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/128

  13. Ramírez ML, Abi-Rezk MN, Veliz JR, Oliva KP, Álvarez JV, Gómez JA, et al. Evaluación pronóstica en pacientes con cardiopatía isquémica tratados mediante cirugía de revascularización miocárdica. Revista Cubana de Cardiología y Cirugía Cardiovascular [Internet]. 19 de julio de 2015 [citado 15 de abril de 2021];21(3):148-55. Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/599

  14. Muñoz YC, Roque FJV, Cuesta DG, Valerón DR. Variables preoperatorias presentes en pacientes con cirugía coronaria sin circulación extracorpórea y su relación con la evolución posquirúrgica precoz. CorSalud [Internet]. 2010 [citado 15 de abril de 2021];2(4):211-20. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=3649381

  15. González GP, Santos ÁGO, Aportela RA, Cerdeira HC, Navas MH, Sarmientos JCG. Complejidad de las lesiones coronarias en pacientes diabéticos. CorSalud [Internet]. 2012 [citado 15 de abril de 2021];4(2):92-6. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=4257358

  16. Dopico RR, Alvarez F de la CH, Ferrero LL, Todo JMP del, Grek OG, Londres JR. Factores pronósticos de eventos cardiacos adversos en pacientes tratados mediante intervencionismo coronario percutáneo electivo. Revista Cubana de Cardiología y Cirugía Cardiovascular [Internet]. 11 de enero de 2012 [citado 15 de abril de 2021];16(4):407-16. Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/210

  17. Ramírez DML. Intervencionismo coronario frente a cirugía de revascularización miocárdica en pacientes con enfermedad multivaso. Revista Cubana de Cardiología y Cirugía Cardiovascular [Internet]. 27 de octubre de 2017 [citado 15 de abril de 2021];23(3):361-70. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/700

  18. Álvarez K, Llerena L, Llerena L, Rodríguez L, López LH, Paredes A. Evolución a corto y mediano plazo de pacientes con diagnóstico de enfermedad coronaria multivaso. Libro de Resúmenes. Congreso de Cardiología.2014.

  19. Vilaú M, Mendoza JL, Leyva AY, Ponte G, Aguilar JM, Rodríguez S. Intervencionismo Coronario Percutáneo en la Enfermedad Multivaso. Impacto de la Complejidad Anatómica. Libro de resúmenes. Congreso Cubano Y Centroamericano de Cardiología. 2018.

  20. Perez LIA, Dominguez AN, Navas MH, Hernández RAG, Aportela RA, Rodriguez ALC. Intervencionismo percutáneo en la enfermedad coronaria de tres vasos. Seguimiento de dos años. Revista Cubana de Cardiología y Cirugía Cardiovascular [Internet]. 17 de septiembre de 2019 [citado 15 de abril de 2021];25(3):301-11. Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/887

  21. He C, Song Y, Wang C, Yao Y, Tang X, Zhao X, et al. Prognostic Value of the Clinical SYNTAX Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention. The American Journal of Cardiology [Internet]. 15 de mayo de 2017 [citado 15 de abril de 2021];119(10):1493-9. Disponible en: https://www.sciencedirect.com/science/article/pii/S0002914917302175

  22. Brown AJ, McCormick LM, Gajendragadkar PR, Hoole SP, West NEJ. Initial SYNTAX Score Predicts Major Adverse Cardiac Events After Primary Percutaneous Coronary Intervention. Angiology [Internet]. 1 de mayo de 2014 [citado 15 de abril de 2021];65(5):408-12. Disponible en: https://doi.org/10.1177/0003319713483542

  23. Zhang Y-J, Iqbal J, Campos CM, Klaveren DV, Bourantas CV, Dawkins KD, et al. Prognostic Value of Site SYNTAX Score and Rationale for Combining Anatomic and Clinical Factors in Decision Making: Insights From the SYNTAX Trial. Journal of the American College of Cardiology [Internet]. 5 de agosto de 2014 [citado 15 de abril de 2021];64(5):423-32. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109714027442

  24. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology [Internet]. 30 de octubre de 2018 [citado 16 de abril de 2021];72(18):2231-64. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109718369419

  25. Naranjo A, Aroche A, Nava MH, Obregón A, Aldama L. Variabilidad Interobservador del Score SYNTAX en pacientes con diagnóstico de Enfermedad Arterial Coronaria Multivaso. Revista Cubana de Cardiología y Cirugía Cardiovascular [Internet]. 4 de junio de 2018 [citado 16 de abril de 2021];24(2):141-54. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/761

  26. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. The Lancet [Internet]. 4 de abril de 2009 [citado 16 de abril de 2021];373(9670):1190-7. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60552-3/abstract

  27. Velazquez EJ, Bonow RO. Revascularization in Severe Left Ventricular Dysfunction. Journal of the American College of Cardiology [Internet]. 17 de febrero de 2015 [citado 19 de abril de 2021];65(6):615-24. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109714072994

  28. Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel M-A, van Es G-A, et al. Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. Journal of the American College of Cardiology [Internet]. 20 de julio de 2010 [citado 19 de abril de 2021];56(4):272-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109710018024

  29. Bundhun PK, Sookharee Y, Bholee A, Huang F. Application of the SYNTAX score in interventional cardiology. Medicine (Baltimore) [Internet]. 14 de julio de 2017 [citado 19 de abril de 2021];96(28). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515749/

  30. Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, et al. 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents: A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). Journal of the American College of Cardiology [Internet]. 29 de abril de 2014 [citado 19 de abril de 2021];63(16):1617-25. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109714004057

  31. Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal [Internet]. 1 de octubre de 2014 [citado 15 de abril de 2021];35(37):2541-619. Disponible en: https://doi.org/10.1093/eurheartj/ehu278

  32. Holm NR, Mäkikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. The Lancet [Internet]. 18 de enero de 2020 [citado 19 de abril de 2021];395(10219):191-9. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32972-1/abstract

  33. Thuijs DJFM, Kappetein AP, Serruys PW, Mohr F-W, Morice M-C, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. The Lancet [Internet]. 12 de octubre de 2019 [citado 19 de abril de 2021];394(10206):1325-34. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31997-X/abstract

  34. Deb S, Fremes SE. The SYNTAX battle in the war between stent and bypass: A landmark surgical win. The Journal of Thoracic and Cardiovascular Surgery [Internet]. 1 de noviembre de 2016 [citado 19 de abril de 2021];152(5):1241-2. Disponible en: https://www.jtcvs.org/article/S0022-5223(16)30844-3/abstract

  35. Fabio Mangiacapra, Michael Maeng, Guillaume Cayla, Alexandra J. Lansky, Pascal Meier, Philippe Kolh. EXCEL and NOBLE: stents or surgery for left main stem stenosis? EuroIntervention [Internet]. 4 de agosto de 2017;13(5):e604-8. Disponible en: https://eurointervention.pcronline.com/article/excel-and-noble-stents-or-surgery-for-left-main-stem-stenosis

  36. Varenhorst C, Lindholm M, Sarno G, Olivecrona G, Jensen U, Nilsson J, et al. Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents. Clin Res Cardiol [Internet]. 1 de septiembre de 2018 [citado 19 de abril de 2021];107(9):816-23. Disponible en: https://doi.org/10.1007/s00392-018-1252-0

  37. Nielsen EE, Feinberg J, Greenhalgh J, Hounsome J, Sethi NJ, Safi S, et al. Drug‐eluting stents versus bare‐metal stents for stable ischaemic heart disease. Cochrane Database Syst Rev [Internet]. 16 de diciembre de 2016 [citado 19 de abril de 2021];2016(12). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463946/

  38. Safarian H, Alidoosti M, Shafiee A, Salarifar M, Poorhosseini H, Nematipour E. The SYNTAX Score Can Predict Major Adverse Cardiac Events Following Percutaneous Coronary Intervention. Heart Views [Internet]. 2014 [citado 19 de abril de 2021];15(4):99-105. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348991/

  39. Brito J, Teles R, Almeida M, de Araújo Gonçalves P, Raposo L, Sousa P, et al. Predictive value of SYNTAX score in risk stratification of patients undergoing unprotected left main coronary artery angioplasty. J Invasive Cardiol. diciembre de 2011;23(12):494-9.

  40. Girasis C, Garg S, Räber L, Sarno G, Morel M-A, Garcia-Garcia HM, et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. European Heart Journal [Internet]. 1 de diciembre de 2011 [citado 19 de abril de 2021];32(24):3115-27. Disponible en: https://doi.org/10.1093/eurheartj/ehr369

  41. Buffolo Enio, Stein Alberto Juffe. Estudio SYNTAX de la evidencia a la desobediencia. Rev Bras Cir Cardiovasc [Internet]. 2013 June [cited 2021 Apr 19] ; 28( 2 ): III-V. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382013000200002&lng=en https://doi.org/10.5935/1678-9741.20130023.




2020     |     www.medigraphic.com